Trends in Pharmacological Sciences

Contents page + Editorial Board
pp. i-i(1)

Hydrogen sulfide: from the smell of the past to the mediator of the future?
pp. 609-611(3)
Authors: Moore P.K.; Bhatia M.; Moochhala S.

A site-specific polymeric drug carrier for renal disease treatment
pp. 611-613(3)
Author: Kishida A.

Interleukin 4 treatment of psoriasis: are pleiotropic cytokines suitable therapies for autoimmune diseases?
pp. 613-616(4)
Author: Martin R.

Sparing animals and progressing in science
pp. 616-617(2)
Authors: Guaitani A.; Filippeschi S.; Garattini S.

Fundamental molecular mechanism of the CNS effects of TRH
pp. 617-618(2)
Author: Yarbrough G.G.

Assessing predictors of drug-induced torsade de pointes
pp. 619-625(7)
Authors: Belardinelli L.; Antzelevitch C.; Vos M.A.

Non-visual GRKs: are we seeing the whole picture?
pp. 626-633(8)
Authors: Willets J.M.; Challiss R.A.J.; Nahorski S.R.

Opioid hyperalgesia and tolerance versus 5-HT_1A receptor-mediated inverse tolerance
pp. 634-639(6)
Authors: Xu X.-J.; Colpaert F.; Wiesenfeld-Hallin Z.

Leukocyte and endothelial cell adhesion molecules as targets for therapeutic interventions in inflammatory disease
pp. 640-647(8)
Authors: Ulbrich H.; Eriksson E.E.; Lindbom L.

Fatty acid-sensitive two-pore domain K⁺ channels
pp. 648-654(7)
Author: Kim D.

Techniques: Plasmon-waveguide resonance (PWR) spectroscopy as a tool to study ligand-GPCR interactions
pp. 655-659(5)
Authors: Tollin G.; Salamon Z.; Hruby V.J.